参七脑康胶囊联合神经节苷脂钠注射液治疗急性颅脑损伤患者的临床效果及对神经细胞因子、suPAR、IGF-Ⅱ、UCH-L1水平的影响

doi:doi：10.3969/j.issn.1674-4985.2023.09.009

中国医学创新

2023, Vol. 20

Issue (9): 36-40 DOI: doi：10.3969/j.issn.1674-4985.2023.09.009

Clinical research

Current Issue | Archive | Adv Search

Clinical Effect of Shenqi Naokang Capsules Combined with Ganglioside Sodium Injection on Patients with Acute Brain Injury and Its Influence on the Levels of Neurocytokines, suPAR, IGF-Ⅱ and UCH-L1

CUI Bo

First-author's address: Jiamusi Central Hospital, Heilongjiang Province, Jiamusi 154002, China

Abstract
Figure/Table
References
Related Citation (2)

Download: PDF (1087 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Received: 26 September 2022

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CUI Bo

Cite this article:

CUI Bo. Clinical Effect of Shenqi Naokang Capsules Combined with Ganglioside Sodium Injection on Patients with Acute Brain Injury and Its Influence on the Levels of Neurocytokines, suPAR, IGF-Ⅱ and UCH-L1[J]. 中国医学创新, 2023, 20(9): 36-40.

URL:

http://www.zgyxcx.com/EN/doi：10.3969/j.issn.1674-4985.2023.09.009 OR http://www.zgyxcx.com/EN/Y2023/V20/I9/36